Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
editorial
. 1995 Sep;101(3):387–389. doi: 10.1111/j.1365-2249.1995.tb03123.x

The role of cAMP regulation in controlling inflammation.

A R Moore, D A Willoughby
PMCID: PMC1553238  PMID: 7664483

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  2. Bulut V., Severn A., Liew F. Y. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem Biophys Res Commun. 1993 Sep 15;195(2):1134–1138. doi: 10.1006/bbrc.1993.2162. [DOI] [PubMed] [Google Scholar]
  3. Capasso F., Dunn C. J., Yamamoto S., Willoughby D. A., Giroud J. P. Further studies on carrageenan-induced pleurisy in rats. J Pathol. 1975 Jun;116(2):117–124. doi: 10.1002/path.1711160208. [DOI] [PubMed] [Google Scholar]
  4. Chan S. C., Hanifin J. M. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes. J Lab Clin Med. 1993 Jan;121(1):44–51. [PubMed] [Google Scholar]
  5. Di Marzo V., Galadari S. H., Tippins J. R., Morris H. R. Interactions between second messengers: cyclic AMP and phospholipase A2- and phospholipase C-metabolites. Life Sci. 1991;49(4):247–259. doi: 10.1016/0024-3205(91)90011-y. [DOI] [PubMed] [Google Scholar]
  6. Dunn C. J., Willoughby D. A., Giroud J. P., Yamamoto S. An appraisal of the interrelationships between prostaglandins and cyclic nucleotides in inflammation. Biomedicine. 1976;24(4):214–220. [PubMed] [Google Scholar]
  7. Gallin J. I., Sandler J. A., Clyman R. I., Manganiello V. C., Vaughan M. Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. J Immunol. 1978 Feb;120(2):492–496. [PubMed] [Google Scholar]
  8. Hall I. P. Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses. Br J Clin Pharmacol. 1993 Jan;35(1):1–7. doi: 10.1111/j.1365-2125.1993.tb05662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ham E. A., Soderman D. D., Zanetti M. E., Dougherty H. W., McCauley E., Kuehl F. A., Jr Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4349–4353. doi: 10.1073/pnas.80.14.4349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harvath L., Robbins J. D., Russell A. A., Seamon K. B. cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness. J Immunol. 1991 Jan 1;146(1):224–232. [PubMed] [Google Scholar]
  11. Henney C. S., Bourne H. R., Lichtenstein L. M. The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol. 1972 Jun;108(6):1526–1534. [PubMed] [Google Scholar]
  12. Kuehl F. A., Jr, Zanetti M. E., Soderman D. D., Miller D. K., Ham E. A. Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis. 1987 Jul;136(1):210–213. doi: 10.1164/ajrccm/136.1.210. [DOI] [PubMed] [Google Scholar]
  13. Marone G., Columbo M., Triggiani M., Cirillo R., Genovese A., Formisano S. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem Pharmacol. 1987 Jan 1;36(1):13–20. doi: 10.1016/0006-2952(87)90377-7. [DOI] [PubMed] [Google Scholar]
  14. Nicholson C. D., Challiss R. A., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci. 1991 Jan;12(1):19–27. doi: 10.1016/0165-6147(91)90484-a. [DOI] [PubMed] [Google Scholar]
  15. Nielson C. P. Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J Immunol. 1987 Oct 1;139(7):2392–2397. [PubMed] [Google Scholar]
  16. Novogrodsky A., Rubin A. L., Stenzel K. H. Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens. J Immunol. 1979 Jan;122(1):1–7. [PubMed] [Google Scholar]
  17. Ottonello L., Morone M. P., Dapino P., Dallegri F. Cyclic AMP-elevating agents down-regulate the oxidative burst induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) in adherent neutrophils. Clin Exp Immunol. 1995 Sep;101(3):502–506. doi: 10.1111/j.1365-2249.1995.tb03141.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pierce N. F., Greenough W. B., 3rd, Carpenter C. C., Jr Vibrio cholerae enterotoxin and its mode of action. Bacteriol Rev. 1971 Mar;35(1):1–13. doi: 10.1128/br.35.1.1-13.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Renz H., Gong J. H., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol. 1988 Oct 1;141(7):2388–2393. [PubMed] [Google Scholar]
  20. Rivkin I., Neutze J. A. Influence of cyclic nucleotides and a phosphodiesterase inhibitor on in vitro human blood neutrophil chemotaxis. Arch Int Pharmacodyn Ther. 1977 Aug;228(2):196–204. [PubMed] [Google Scholar]
  21. SUTHERLAND E. W., RALL T. W. Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J Biol Chem. 1958 Jun;232(2):1077–1091. [PubMed] [Google Scholar]
  22. Seamon K. B., Daly J. W. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1986;20:1–150. [PubMed] [Google Scholar]
  23. Torphy T. J., Undem B. J. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax. 1991 Jul;46(7):512–523. doi: 10.1136/thx.46.7.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weissmann G., Dukor P., Zurier R. B. Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol. 1971 Jun 2;231(22):131–135. doi: 10.1038/newbio231131a0. [DOI] [PubMed] [Google Scholar]
  25. Willoughby D. A., Dunn C. J., Yamamoto S., Capasso F., Deporter D. A., Giroud J. P. Calcium pyrophosphate-induced pleurisy in rats: a new model of acute inflammation. Agents Actions. 1975 Feb;5(1):35–38. doi: 10.1007/BF02027156. [DOI] [PubMed] [Google Scholar]
  26. Yamamoto S., Dunn C. J., Capasso F., Deporter D. A., Willoughby D. A. Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs. J Pathol. 1975 Oct;117(2):65–73. doi: 10.1002/path.1711170202. [DOI] [PubMed] [Google Scholar]
  27. Yamamoto S., Dunn C. J., Deporter D. A., Capasso F., Willoughby D. A., Huskinsson E. C. A model for the quantitative study of Arthus (immunologic) hypersensitivity in rats. Agents Actions. 1975 Oct;5(4):374–377. doi: 10.1007/BF02205246. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES